TISSUE-SPECIFIC AND DEVELOPMENTAL REGULATION OF THE RAT INSULIN-II GENE ENHANCER, RIPE3, IN TRANSGENIC MICE

The rat insulin II gene enhancer, RIPE3 (-126 to -86), mediates beta-i slet cell-specific activity in transfection assays, To investigate the in vivo activity of RIPE3, we generated mice carrying a transgene con sisting of three copies of RIPE3 linked to a minimal chicken ovalbumin promoter in conjunction with sequences encoding the human growth horm one gene. 13 transgenic mice were obtained, 11 of which expressed the transgene, as determined by serum radioimmunoassay for human growth ho rmone. Expression of the transgene was assessed for cell specificity b y immunocytochemistry. The pancreatic islet cells invariably stained f or growth hormone, while the acinar and ductal cells did not. Staining of adjacent sections for insulin, glucagon, and somatostatin revealed that growth hormone was expressed in the beta-cell in all of the mice analyzed, but in some mice alpha-cells also contained growth hormone. RNase protection analysis revealed that the tissues that consistently express the transgene in these animals are the pancreas and brain. De velopmental analysis revealed that the transgene was expressed in the pancreatic bud at embryonic day 9.5, corresponding to the temporal exp ression pattern of the insulin gene. These results signify that an ele ment as small as 41 base pairs is capable of regulating pancreatic tem poral and spatial gene expression in vivo.